[18F]FDG PET/MRI Of Patients With Chronic Pain Alters Management: Early Experience.
Daehyun Yoon1, Deepak Behera1, Dawn Holley1, Pamela Gallant1, Ma Agnes Martinez Ith2, Ian Carroll3, Matthew Smuck2, Brian Hargreaves1, and Sandip Biswal1
1Radiology, Stanford University, Palo Alto, CA, United States, 2Orthopaedic Surgery, Stanford University, Palo Alto, CA, United States, 3Anesthesia, Stanford University, Palo Alto, CA, United States
The chronic
pain sufferer is currently faced with a lack of objective tools to identify the
source of their pain. Increased inflammation of the nervous system, vessels,
muscles, and other tissues in chronic pain sufferers and
[18F]fluorodeoxyglucose positron emission tomography/magnetic resonance imaging
([18F]FDG PET/MRI) has emerged as a sensitive clinical tool to identify
increased inflammation. We plan to develop clinical [18F]FDG PET/MRI method to
more accurately localize sites of hypermetabolic foci as it relates to pain
generators. Early clinical results suggest
that [18F]FDG PET/MRI can identify abnormalities in chronic pain patients and can
immediately affect their management.
This abstract and the presentation materials are available to members only;
a login is required.
